Forte Biosciences, Inc.

FBRX

$14.49

Name : Forte Biosciences, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $180,152,048.00

EPSttm : -0.08

Forte Biosciences, Inc.

$14.49

2.91%

$0.41

Float Short %

4.46

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

-0.08

EPS Last/This Y

7.74

EPS This/Next Y

1.11

Price

14.27

Target Price

63.33

Analyst Recom

Performance Q

23.32

Relative Volume

0.65

Beta

3.26

Ticker: FBRX

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	FBRX	12.19	8.25	0.00	37
2025-10-21	FBRX	11.7	0.89	0.00	70
2025-10-22	FBRX	11.54	0.89	0.00	70
2025-10-23	FBRX	12.09	0.89	0.00	70
2025-10-24	FBRX	12.13	0.58	999.99	90
2025-10-27	FBRX	12.95	0.58	999.99	90
2025-10-28	FBRX	13.46	0.58	999.99	90
2025-10-29	FBRX	14.22	0.58	999.99	90
2025-10-30	FBRX	13.25	0.60	0.00	91
2025-10-31	FBRX	12.83	0.60	0.00	91
2025-11-03	FBRX	11.65	0.60	0.00	91
2025-11-04	FBRX	10.99	0.60	0.00	91
2025-11-05	FBRX	10.31	0.60	0.00	91
2025-11-06	FBRX	11.55	0.60	0.00	91
2025-11-07	FBRX	12.22	0.44	0.00	111
2025-11-10	FBRX	13.55	0.43	0.00	113
2025-11-11	FBRX	13.91	0.43	0.00	113
2025-11-12	FBRX	14.43	0.43	999.99	113
2025-11-13	FBRX	14.12	0.68	999.99	133
2025-11-14	FBRX	14.42	0.82	7.50	144
2025-11-17	FBRX	14.1	1.00	0.00	150
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	FBRX	12.19	76.5	-	-4.43
2025-10-21	FBRX	11.79	76.5	-	-4.43
2025-10-22	FBRX	11.66	76.5	-	-4.43
2025-10-23	FBRX	12.14	76.5	-	-4.43
2025-10-24	FBRX	12.15	76.5	-	-4.43
2025-10-27	FBRX	12.98	76.5	-	-4.43
2025-10-28	FBRX	13.46	76.5	-	-4.43
2025-10-29	FBRX	14.39	76.5	-	-4.43
2025-10-30	FBRX	13.27	76.5	-	-4.43
2025-10-31	FBRX	12.94	76.5	-	-4.43
2025-11-03	FBRX	11.68	76.5	-	-4.43
2025-11-04	FBRX	11.02	76.5	-	-4.43
2025-11-05	FBRX	10.62	76.5	-	-4.43
2025-11-06	FBRX	11.43	76.5	-	-4.43
2025-11-07	FBRX	12.08	76.5	-	-4.43
2025-11-10	FBRX	13.67	76.5	-	-4.43
2025-11-11	FBRX	14.09	76.5	-	-4.43
2025-11-12	FBRX	14.45	76.5	-	-4.43
2025-11-13	FBRX	13.95	76.5	-	-4.43
2025-11-14	FBRX	14.06	76.5	-	-4.43
2025-11-17	FBRX	14.27	76.5	-	-4.43
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	FBRX	0.00	44.93	1.63
2025-10-21	FBRX	0.00	44.93	1.63
2025-10-22	FBRX	0.00	44.93	1.63
2025-10-23	FBRX	0.00	44.93	1.63
2025-10-24	FBRX	0.00	44.93	1.63
2025-10-27	FBRX	0.00	47.48	2.46
2025-10-28	FBRX	0.00	47.48	2.46
2025-10-29	FBRX	0.00	47.48	2.46
2025-10-30	FBRX	0.00	47.48	2.46
2025-10-31	FBRX	0.00	47.48	2.46
2025-11-03	FBRX	0.00	44.94	2.46
2025-11-04	FBRX	0.00	44.94	2.46
2025-11-05	FBRX	0.00	44.94	2.46
2025-11-06	FBRX	0.00	44.94	2.46
2025-11-07	FBRX	0.00	44.94	2.46
2025-11-10	FBRX	0.00	44.30	2.46
2025-11-11	FBRX	0.00	44.30	2.46
2025-11-12	FBRX	0.00	44.30	4.46
2025-11-13	FBRX	0.00	44.30	4.46
2025-11-14	FBRX	0.00	44.30	4.46
2025-11-17	FBRX	0.00	41.06	4.46
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.96

Avg. EPS Est. Current Quarter

-1.07

Avg. EPS Est. Next Quarter

-1.04

Insider Transactions

Institutional Transactions

41.06

Beta

3.26

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.7

Max Drawdown 5-Year %

-99.6

Target Price

63.33

P/E

Forward P/E

PEG

P/S

P/B

2.16

P/Free Cash Flow

EPS

-4.44

Average EPS Est. Cur. Y

-4.43

EPS Next Y. (Est.)

-3.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.65

Return on Equity vs Sector %

-70

Return on Equity vs Industry %

-55.1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.05

EBIT Estimation

Forte Biosciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 14

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today

news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance

stock history FBRX – Forte Biosciences Inc invest stock market

stock prices FBRX premarket after hours

ticker FBRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: FBRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y